Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Opinion
  • Published:

Sodium thiosulfate in the treatment of calcific uremic arteriolopathy

Abstract

Calcific uremic arteriolopathy (CUA; also known as calciphylaxis) is a life-threatening condition observed mostly in patients on dialysis. The key histopathologic features of CUA include media calcification of small arteries, associated with endovascular fibrosis and thrombosis. Several risk factors for CUA are related to disturbances in bone and mineral metabolism; current treatments largely aim to normalize these disturbances by lowering serum calcium phosphate concentration and thereby preventing, or even reversing, calcium phosphate oversaturation, precipitation and, finally, calcification. Administration of sodium thiosulfate, which sequesters calcium ions to form highly soluble calcium thiosulfate complexes, can prevent calcium phosphate precipitation. As randomized controlled studies on sodium thiosulfate are lacking, this Perspectives article focuses on case reports and case series; in these reports the compound seemed to be effective and was not associated with serious short-term adverse events. Large clinical trials to evaluate the efficacy and long-term safety of sodium thiosulfate are clearly warranted.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Calcific uremic arteriolopathy of the right lower leg in a 77-year-old female patient with end-stage renal disease.

Similar content being viewed by others

References

  1. Rogers, N. M., Teubner, D. J. & Coates, P. T. Calcific uremic arteriolopathy: advances in pathogenesis and treatment. Semin. Dial. 20, 150–157 (2007).

    Article  Google Scholar 

  2. Nigwekar, S. U., Wolf, M., Sterns, R. H. & Hix, J. K. Calciphylaxis from nonuremic causes: a systematic review. Clin. J. Am. Soc. Nephrol. 3, 1139–1143 (2008).

    Article  Google Scholar 

  3. Angelis, M., Wong, L. L., Myers, S. A. & Wong, L. M. Calciphylaxis in patients on hemodialysis: a prevalence study. Surgery 122, 1083–1089 (1997).

    Article  CAS  Google Scholar 

  4. Fischer, A. H. & Morris, D. J. Pathogenesis of calciphylaxis: study of three cases with literature review. Hum. Pathol. 26, 1055–1064 (1995).

    Article  CAS  Google Scholar 

  5. Au, S. & Crawford, R. I. Three-dimensional analysis of a calciphylaxis plaque: clues to pathogenesis. J. Am. Acad. Dermatol. 47, 53–57 (2002).

    Article  Google Scholar 

  6. Schlieper, G., Westenfeld, R., Brandenburg, V. & Ketteler, M. Inhibitors of calcification in blood and urine. Semin. Dial. 20, 113–121 (2007).

    Article  Google Scholar 

  7. Schäfer, C. et al. The serum protein α2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. J. Clin. Invest. 112, 357–366 (2003).

    Article  Google Scholar 

  8. Cranenburg, E. C. et al. The circulating inactive form of matrix Gla Protein (ucMGP) as a biomarker for cardiovascular calcification. J. Vasc. Res. 45, 427–436 (2008).

    Article  CAS  Google Scholar 

  9. Coates, T. et al. Cutaneous necrosis from calcific uremic arteriolopathy. Am. J. Kidney Dis. 32, 384–391 (1998).

    Article  CAS  Google Scholar 

  10. Brandenburg, V. M., Floege, J. & Ketteler, M. Calcific uremic arteriolopathy (CUA): international collaborative calciphylaxis network (ICCN) [abstract]. Presented at Renal Week 2008, ASN: SA-PO2843 (2008).

  11. Hayden, M. R., Tyagi, S. C., Kolb, L., Sowers, J. R. & Khanna, R. Vascular ossification-calcification in metabolic syndrome, type 2 diabetes mellitus, chronic kidney disease, and calciphylaxis-calcific uremic arteriolopathy: the emerging role of sodium thiosulfate. Cardiovasc. Diabetol. 4, 4 (2005).

    Article  Google Scholar 

  12. Weenig, R. H. Pathogenesis of calciphylaxis: Hans Selye to nuclear factor kappa-B. J. Am. Acad. Dermatol. 58, 458–471 (2008).

    Article  Google Scholar 

  13. Fine, A. & Fontaine, B. Calciphylaxis: the beginning of the end? Perit. Dial. Int. 28, 268–270 (2008).

    PubMed  Google Scholar 

  14. Hayden, M. R., Goldsmith, D., Sowers, J. R. & Khanna, R. Calciphylaxis: calcific uremic arteriolopathy and the emerging role of sodium thiosulfate. Int. Urol. Nephrol. 40, 443–451 (2008).

    Article  CAS  Google Scholar 

  15. Raymond, C. B. & Wazny, L. D. Sodium thiosulfate, bisphosphonates, and cinacalcet for treatment of calciphylaxis. Am. J. Health Syst. Pharm. 65, 1419–1429 (2008).

    Article  CAS  Google Scholar 

  16. Pasch, A. et al. Sodium thiosulfate prevents vascular calcifications in uremic rats. Kidney Int. 74, 1444–1453 (2008).

    Article  CAS  Google Scholar 

  17. Brucculeri, M., Cheigh, J., Bauer, G. & Serur, D. Long-term intravenous sodium thiosulfate in the treatment of a patient with calciphylaxis. Semin. Dial. 18, 431–434 (2005).

    Article  Google Scholar 

  18. Bodell, M. A., Deng, J. & Spector, D. A. Sodium thiosulfate (STS) prevents vascular calcification (VC) in rats with adenine-induced kidney disease [abstract]. Presented at Renal Week 2008, ASN: F-PO1822 (2008).

  19. Cicone, J. S., Petronis, J. B., Embert, C. D. & Spector, D. A. Successful treatment of calciphylaxis with intravenous sodium thiosulfate. Am. J. Kidney Dis. 43, 1104–1108 (2004).

    Article  Google Scholar 

  20. Guerra, G., Shah, R. C. & Ross, E. A. Rapid resolution of calciphylaxis with intravenous sodium thiosulfate and continuous venovenous haemofiltration using low calcium replacement fluid: case report. Nephrol. Dial. Transplant. 20, 1260–1262 (2005).

    Article  Google Scholar 

  21. Araya, C. E., Fennell, R. S., Neiberger, R. E. & Dharnidharka, V. R. Sodium thiosulfate treatment for calcific uremic arteriolopathy in children and young adults. Clin. J. Am. Soc. Nephrol. 1, 1161–1166 (2006).

    Article  CAS  Google Scholar 

  22. Hayden, M. R., Kolb, L. G. & Khanna, R. Calciphylaxis and the cardiometabolic syndrome. J. Cardiometab. Syndr. 1, 76–79 (2006).

    Article  Google Scholar 

  23. Mataic, D. & Bastani, B. Intraperitoneal sodium thiosulfate for the treatment of calciphylaxis. Ren. Fail. 28, 361–363 (2006).

    Article  Google Scholar 

  24. Meissner, M. et al. Sodium thiosulphate as a promising therapeutic option to treat calciphylaxis. Dermatology 212, 373–376 (2006).

    Article  CAS  Google Scholar 

  25. Ackermann, F. et al. Sodium thiosulfate as first-line treatment for calciphylaxis. Arch. Dermatol. 143, 1336–1337 (2007).

    Article  Google Scholar 

  26. Baker, B. L., Fitzgibbons, C. A. & Buescher, L. S. Calciphylaxis responding to sodium thiosulfate therapy. Arch. Dermatol. 143, 269–270 (2007).

    Article  Google Scholar 

  27. Li, J. Z. & Huen, W. Images in clinical medicine. Calciphylaxis with arterial calcification. N. Engl. J. Med. 357, 1326 (2007).

    Article  CAS  Google Scholar 

  28. Kyritsis, I. et al. Combination of sodium thiosulphate, cinacalcet, and paricalcitol in the treatment of calciphylaxis with hyperparathyroidism. Int. J. Artif. Organs 31, 742–744 (2008).

    Article  CAS  Google Scholar 

  29. Musso, C. G. et al. Oral sodium thiosulfate solution as a secondary preventive treatment for calciphylaxis in dialysis patients. Saudi J. Kidney Dis. Transpl. 19, 820–821 (2008).

    PubMed  Google Scholar 

  30. Soni, S. & Leslie, W. D. Bone scan findings in metastatic calcification from calciphylaxis. Clin. Nucl. Med. 33, 502–504 (2008).

    Article  Google Scholar 

  31. Subramaniam, K., Wallace, H., Sinniah, R. & Saker, B. Complete resolution of recurrent calciphylaxis with long-term intravenous sodium thiosulfate. Australas. J. Dermatol. 49, 30–34 (2008).

    Article  Google Scholar 

  32. Tindni, A., Gaurav, K. & Panda, M. Non-healing painful ulcers in a patient with chronic kidney disease and role of sodium thiosulfate: a case report. Cases J. 1, 178 (2008).

    Article  Google Scholar 

  33. Meade, D., Lacson, E., Wang, W. & Lazarus, M. Sodium thiosulfate therapy for calciphylaxis in hemodialysis patients [abstract]. Presented at Renal Week 2008, ASN: SA-PO2775 (2008).

  34. Hackett, B. C., McAleer, M. A., Sheehan, G., Powell, F. C. & O'Donnell, B. F. Calciphylaxis in a patient with normal renal function: response to treatment with sodium thiosulfate. Clin. Exp. Dermatol. 34, 39–42 (2009).

    Article  CAS  Google Scholar 

  35. Riegert-Johnson, D. L., Kaur, J. S. & Pfeifer, E. A. Calciphylaxis associated with cholangiocarcinoma treated with low-molecular-weight heparin and vitamin K. Mayo Clin. Proc. 76, 749–752 (2001).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Georg Schlieper.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schlieper, G., Brandenburg, V., Ketteler, M. et al. Sodium thiosulfate in the treatment of calcific uremic arteriolopathy. Nat Rev Nephrol 5, 539–543 (2009). https://doi.org/10.1038/nrneph.2009.99

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrneph.2009.99

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing